Several recent observations
suggest that Schwann cell (SC) differentiation, including myelin formation, is dependent upon the development of basal lamina which characteristically surrounds each axon-SC unit in peripheral nerve. This dependence can be tested in a neuron-SC culture system developed in our laboratory in which SC differentiation, including basal lamina formation and myelination, is faithfully reproduced.
The use of serum-free, defined medium (DM) with this culture system allows axon-driven SC proliferation but not basal lamina formation or myelination.
We previously demonstrated that ascorbic acid, in the presence of a nondialyzable serum factor(s), stimulates basal lamina assembly and myelin formation with similar dose-response relationships (Eldridge et al., 1997) . We hypothesized that ascorbic acid acts to promote SC myelination indirectly, by enabling the assembly of basal lamina. We now provide support for this hypothesis by demonstrating the following.
(1) Pepsin-resistant triple-helical collagen molecules were produced only by SCs grown in the presence of ascorbic acid, suggesting that triple-helical type IV collagen may mediate the effect of ascorbic acid on basal lamina formation.
(2) The formation of myelin by oligodendrocytes, which myelinate axons in the CNS without the concomitant deposition of basal lamina, was little affected by ascorbic acid, suggesting that the biosynthesis and assembly of myelin per se does not require ascorbic acid. (3) The provision of exogenous basal lamina matrix to SCs grown with neurons in DM without ascorbic acid promoted control levels of myelination (and basal lamina formation); the provision of exogenous fibrillar collagen matrix did not. (4) Purified laminin promoted control levels of myelination in the absence of ascorbic acid, but purified type IV collagen and heparan sulfate proteoglycan (HSPG) did not. Laminin caused SCs to assemble basal lamina-like structures that contained not only laminin but also HSPG and non-triple-helical type IV collagen. Thus, several types of experiments demonstrate that SC myelin formation can be controlled by regulating the ability of the SC to assemble basal lamina, illustrating that acquisition of basal lamina is a crucial prefatory step for further SC differentiation.
The differentiation of certain cells of neural crest origin into SCs of the peripheral nerve trunk involves a number of stages, including basal lamina formation, proliferation, and eventually ensheathment or myelination of axons (reviewed in Webster and Favilla, 1984) . Although these stages overlap temporally during development in vivo, they can be experimentally separated, both in vivo and in vitro (reviewed in Bunge and Bunge, 1984) and thus can be studied relatively independently from one another. The neuron, via its axon, has been shown to exert control over several stages of Schwann cell (SC) differentiation; these include the expression of basal lamina components Dean et al., 1986 ) and formation of basal lamina , SC mitosis (Wood and Bunge, 1975; McCarthy and Partlow, 1976; Salzer and Bunge, 1980; Salzer et al., 1980a , b, DeVries et al., 1982 Ratner et al., 1987) , and the expression and processing of myelin proteins and lipids (Mirsky et al., 1980; Brockes et al., 198 1; Politis et al., 1982; Poduslo et al., 1985; Brunden and Poduslo, 1987) .
Tissue culture studies have shown that, in addition to the axon, the basal lamina may also play important roles in SC differentiation. Two glycoproteins related to basal lamina, laminin and fibronectin, have been shown to stimulate SC division by unknown mechanisms (Baron-Van Evercooren et al., 1982; McGarvey et al., 1984; . Work from our laboratory has demonstrated that there exists a close correlation between the ability of the SC to form a basal lamina and to myelinate axons. Moya et al. (1980) initially reported that SCs cultured with neurons in serum-free defined medium (DM) are able to proliferate in response to axonal contact but do not form either basal lamina or myelin. Providing such SCneuron cultures with standard myelinating medium, containing serum and chick embryo extract, results in the assembly of basal laminae and the establishment of normal SC-axon relationships, including myelination. We have recently presented evidence ) that the components of standard myelinating medium essential for the promotion of both basal lamina assembly and myelination are ascorbic acid (the critical component of embryo extract) and a nondialyzable serum component(s). The serum component(s) alone has little detectable effect but is essential for allowing ascorbic acid to manifest its ability to promote these aspects of SC differentiation; ascorbic et al. -Control of Myelin Formation by Basal Lamina acid in the absence of serum promotes only the irregular deposition of basal lamina components and the formation of small quantities of myelin. These results suggested that the SC requires basal lamina in order to form myelin and that ascorbic acid enables the SC to assemble basal lamina rather than influencing myelination directly. The results of the present study support this concept of the mechanism by which ascorbic acid influences peripheral myelination.
obtained from Collaborative Research. EHS sarcoma laminin was alSO obtained from Bethesda Research Laboratories (Gaithersburg, MD) and as a gift from Dr. E. Crouch (Dept. Pathology, Jewish Hosp., St. Louis, MO);, when laminin from these sources was used, all media were filterstenhzed. Type IV collagen in 0.5 M acetic acid purilied from the EHS sarcoma was obtained from Collaborative Research and from Bethesda Research Laboratories; it was dialyzed aseptically into DM salt base before use. Large, low-density HSPG purified from the EHS sarcoma was generously supplied by Dr. John Hassell (NIDR, NIH, Bethesda, MD); the lyophilized proteoglycan was dissolved in 4 M guanidine-HCl/50 mM phosphate, pH 7.4, and then dialyzed aseptically into PBS.
Materials and Methods
Cell culture. Dissociated cell cultures containing purified populations of sensory neurons and SCs were prepared from embryonic day (E) 15 Sprague-Dawley rat dorsal root ganglia as previously described . Briefly, cultures were cycled on and off 1O-5 M fluorodeoxyuridine in serum-containing medium for 2 weeks, grown in DM for 1 week, seeded with l-2 x lo4 purified SCs per culture, and maintained in DM for 4 weeks to allow the generation of a full SC population. DM contained insulin, transferrin, progesterone, putrescine, selenium, and 2.5s NGF in a 1: 1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 (GIBCO, Grand Island, NY); the total protein concentration was 15.1 p&ml. Fully repopulated SC-neuron cultures were maintained in DM or various supplemented DMs for 2 weeks, after which time they were metabolically labeled or processed for light or electron microscopy (see below).
Metabolic labeling of cultures. Triplicate SC-neuron cultures were labeled for 24 hr at the end of the 2 week suunlementation period. Cultures grown in DM were labeled in medium A [leucine-free Eagle's MEM containing 2.5s NGF, transferrin, insulin, putrescine, progesterone, and selenium at the same concentrations as in DM, and with 5.2 r&ml L-leucine (10% of the normal concentration) and 200 &i/ml L-3,4,5-3H-leucine (New England Nuclear, Boston]. Cultures grown in DM supplemented with ascorbic acid were labeled in medium A plus 50 fig/ml ascorbic acid. Cultures grown in standard myelinating medium (Moya et al., 1980) or DM supplemented with HPS plus embryo extract were labeled in medium A plus 5% dialyzed HPS plus 50 &ml ascorbic acid. Cultures grown in DM supplemented with dialyzed FBS with or without ascorbic acid were labeled in medium A plus 5% dialyzed FBS with or without 50 &ml ascorbic acid, respectively. In one experiment, cultures in DM were labeled with 3H-leucine either in leucine-free Eagle's MEM plus NGF as described by Carey and Bunge (198 1) , or simply in DM. In 2 experiments, cultures were labeled with 200 rKi/rnl~-?3-methionine in the media in which they were being grown. Labeling media were filter-sterilized; cultures were labeled in 0.4-0.65 ml, and total incorporation of labeled precursor was < 10% of available precursor.
Cultures for study of oligodendrocyte (ODC) myelination were prepared as described for SC-neuron cultures, except seeding used dissociated El9 rat lumbar spinal cord (Wood and Williams, 1984) at 50 x 10) cells per culture. After seeding, cultures were maintained in DM for 2 weeks and then in DM or various supplemented DMs for 4 weeks. To detect myelin-forming SC colonies that form in such cultures (Wood and Williams, 1984) immunocytochemistry (see below) was performed on fixed and permeabilized cultures (Bologna-Sandru et al., 198 1) using antiserum to P, (a gift from Dr. J. Brockes; Brockes et al., 1980) . The location of all P,+, myelin-forming SC colonies was mapped onto graph paper by scanning at 250 x . Cultures were then unmounted, processed for Sudan black staining, and remounted, maintaining orientation. Fields arrayed at 1 mm intervals on a grid covering most of the culture were evaluated at 640 x for the presence of myelin; the density of CNS myelin made quantitation of the number of myelin segments impossible. Fields that had been previously determined to contain P,+ myelin were scored as negative for CNS myelin. DM supplementation. Details have been provided previously . Briefly, serum used for supplementation was human placental cord serum (HPS; prepared from blood obtained locally) or fetal bovine serum (FBS; Hyclone Labs, Logan, UT). In most cases (as indicated), the serum was dialyzed against DM salt base before use in supplementing DM; serum was dialyzed against leucine-free Eagle's minimal essential medium for use in metabolic labeling experiments. L-Ascorbic acid (Sigma, St. Louis) was used at 280 PM (50 &ml). Chick embryo extract (Paul, 1970 ) was used at 5 or 10% (vol/vol). Myelinating medium (MM) contained HPS plus embryo extract (Moya et al., 1980) or dialyzed FBS plus ascorbic acid , as indicated.
Gel overlays. In some experiments, fully populated SC-neuron cultures grown in DM were overlaid with either a fibrous collagen gel (FCG) or a basal lamina gel (BLG) immediately before initiating a DM supplementation experiment. FCGs were prepared by the method of Elsdale and Bard (1972) ; type I collagen-rich rat-tail collagen (prepared in the laboratory by the method of Bomstein, 1958) in 0.1% acetic acid was mixed on ice with l/ 10 vol of a 2: 1 mixture .of 10 x Hank's balanced salt solution: 0.34 N NaOH. The culture medium was drained from the cultures, 0.25 ml of the neutralized collagen solution was added, and the cultures were maintained at 35°C for 20-30 min in order for a gel to form. BLGs were prepared by pipetting 0.25 ml of ice-cold basal lamina matrix [Matrigel, a whole extract of Englebreth-Holm-Swarm (EHS) sarcoma extracellular matrix, (Kleinman et al., 1986) Collaborative Research, Lexington, MA] onto drained cultures and then maintaining them at 35°C for 20-30 min. After gel formation, cultures were given DM, maintained at 35°C for 90 min, and then refed DM or supplemented DM. In some experiments, basal lamina matrix was diluted into ice-cold DM and used as culture medium.
Purijied basal lamina components. A sterile solution of laminin in 50 mM T&/l50 mM NaCl, pH 7.4, purified from the EHS sarcoma was
At the end of the labeling period, media and cell layers were separated and protease inhibitors (Eldridge et al., 1986) added, and all medium samples were made to 4% serum (by adding dialyzed serum or medium A to serum-free or serum-containing samples, respectively). Incorporation of 'H-leucine into protein in medium and sonicated cell layer (see below) samples was determined by precipitation with 10% trichloroacetic acid (TCA) followed by vacuum filtration . SDS-PAGE and fluorography, pepsin digestion, and sonication, and assay of cell layers for DNA were performed as previously described . Immunoprecipitation of metabolically labeled cell layer samples after 4 M guanidme extraction was performed as previously described (Eldridge et al., 1986) .
Assay for medium-associated proteolytic activity. For each culture, at the end of the 24 hr labeling period, the medium was transferred to a microfuge tube and, in some cases, spun 5 min at 1000 x g to remove cell debris (no protease inhibitors were added); the results were the same whether or not the medium was spun. A sample was removed for analysis ("0 hr" of medium incubation in the absence of cells), and the remainder was returned to the appropriate CO, atmosphere at 35°C; 24 hr later an identical medium sample was removed for analysis ("24 hr" of medium incubation in the absence of cells). At both the 0 and 24 hr time points, the medium samples were immediately made to 4% serum, and aliquots were taken for TCA precipitation and SDS-PAGE, as described above.
Quantitation ofmyelination, immunochemistry, and electron microscopy. At the end of the 2 week supplementation period, cultures were fixed and processed for Sudan black staining and myelin qnantitation or processed for immunocytochemistry (in the living state) with antibodies to basal lamina components as previously described . The following antibodies were used: rabbit antibodies to EHS sarcoma laminin and type IV collagen NC1 domain (from Dr. R. mouse monoclonal antibody to basal lamina HSPG (from Dr. C. Eldridge et al., 1986 , rabbit antibodies to EHS sarcoma and to human placental type IV collagen (from Dr. E. Crouch), and rabbit antibodies to EHS sarcoma type IV collagen NC1 domain (from Dr. A. Charonis). All antibodies were specific for the stated antigen, as determined by immunoprecipitation of medium or cell-layer samples from metabolically labeled, differentiated SC-neuron cultures. Some cultures were fixed and embedded for electron microscopy; fascicles were transversely sectioned, stained in thin sections with uranyl acetate and lead citrate, and examined in a Philips 300 EM as previously described Ratner et al., 1986 ). 1.0 -dFBS + A (MM) 100 0.6 + SC-neuron cultures, grown in DM for 4 weeks and then in triplicate in the medium indicated for an additional 2 weeks, were metabolically labeled with 'H-leucine for 24 hr. The culture media were individually assayed for proteolytic activity as described in Materials and Methods. The serum used in experiment 1 was 15% HPS and in experiments 2 and 3 was 15% dialyzed FBS (dFBS). A indicates L-ascorbic acid, at 50 &ml (280 PM); EE indicates 5% chick embryo extract. L Mean of values from 3 cultures per condition. " See . 'p < 0.001 (2-tailed) compared to DM by t test. All other values are not significantly different from DM.
Results
The SC-neuron cultures used in this study contained a purified sensory neuron population repopulated with SCs in a defined medium lacking ascorbic acid and serum. In this medium, SCs are unable to deposit basal lamina or form myelin sheaths. In the first paper in this series , we demonstrated that the addition of ascorbic acid to DM, in the presence of a nondialyzable serum component(s), stimulates SC basal lamina assembly and SC myelin formation with similar doseresponse characteristics. These results suggested a model in which the critical need for ascorbic acid did not derive from a direct effect of that vitamin on SC myelination but, rather, from a direct effect on basal lamina assembly, the latter then enabling the SC to proceed to myelination. The experiments reported here were performed to test this model. SC secretion in defined versus supplemented media SC-neuron cultures were maintained in DM or supplemented DMs for 2 weeks and then labeled with 3H-leucine for 24 hr. The SDS-PAGE pattern of labeled proteins in the medium of cultures grown in DM was (with exceptions discussed below) similar to that when cultures were grown in MM (containing ascorbic acid and serum); many bands representing proteins ranging in size from A4, < 20,000 to > 200,000 were present (cf. Fig. 1 , a, e). Similar results were obtained by 2 additional protocols for labeling cultures grown in DM (cf. Fig. 1 , a-c), including the procedure used initially in this laboratory (Fig. 1 b ; Carey and Bunge, 198 1) . Culture media were also analyzed after an additional 24 hr of incubation in the absence of cells. There was little or no loss of TCA-precipitable cpm (Table 1) or degradation of protein ( Fig. 1, d , f) during this time period, indicating that the accumulation of secreted proteins had not been affected by proteolysis.
The relative amount of protein synthesized and secreted by SCs in DM and MM was quantitated after 3H-leucine labeling by TCA precipitation of medium and cell layer samples, followed by normalization of TCA-precipitable cpm to culture DNA content. As shown in Table 2 , no systematic differences in the quantity of protein synthesized or secreted were found.
Five experiments were analyzed in this way, and although there were often very significant differences in total protein synthesis and/or secretion within a given experiment, the lack of a consistent correlation between the state of SC differentiation and these aspects of protein biosynthesis suggests that such quantitative differences are not a critical factor controlling SC differentiation.
Ascorbic acid is required for the formation of triple-helical collagen Although the SDS-PAGE patterns of proteins secreted by SCs grown with neurons in DM and in MM were similar, some differences were observed, especially in the A4, = 170,000-200,000 region, where procollagens produced by SCs are known to migrate . Whereas the procollagen type IV doublet and other bands known to be collagenase-sensitive were apparent in the medium of cultures in MM (Fig. 2 , g, h), only broad, poorly defined bands were observed in the same region when medium from DM cultures was analyzed ( Fig. 2, a, b) . To determine whether SCs in DM were capable of synthesizing and secreting native, triple-helical collagens, metabolically labeled medium samples were digested with pepsin, which cleaves essentially all proteins, including non-triple-helical collagen domains, but is inactive against triple-helical collagen domains. Whereas pepsin-resistant bands known to correspond to collagen types I and IV were observed in the medium of cultures grown in MM (Fig. 2 , o, p), little, if any, pepsin-resistant collagen was secreted by cultures grown in DM (Fig. 2 , i, j). Identical results were obtained when cell layers were examined for pepsin-resistant collagens (data not shown).
As discussed above, MM differs from DM in that it contains ascorbic acid and serum. To determine the individual effects of these additives on SC biosynthetic processes, cultures were grown and labeled with 3H-leucine in DM supplemented with only ascorbic acid or serum and then analyzed as above. Paralleling the lack of detectable effects on SC differentiation, serum alone did not alter the SDS-PAGE pattern of either total medium proteins (Fig. 2, e, f) or pepsin-resistant collagens (Fig. 2, were grown for 4 weeks in DM and then for 2 weeks in DM (lanes ad) or MM (15% dialyzed FBS plus ascorbic acid; lanes e andf). The cultures were then labeled with 3H-leucine and, in some cases, assayed for medium-associated proteolytic activity as described in Materials and Methods. For 0 hr samples, each lane was loaded with equal TCAprecipitable medium cpm; for 24 hr samples, the lanes were loaded with volumes of medium equal to the corresponding 0 hr samples. The samples were subjected to SDS-PAGE on a linear 5-10% gel followed by fluorography. Lane a, 0 hr sample from a DM culture labeled in DM, lane b, 0 hr sample from a DM culture labeled in leucine-free Eagle's minimal essential medium plus NGF, as described by Carey and Bunge (198 1) ; lanes c and d, 0 (c) and 24 (d) hr samples from a DM culture labeled in leucine-free Eagle's minimal essential medium containing 5.2 pdrnl r.-leucine plus normal DM components; lanes e andJ; 0 (e) and 24 (f) hr samples from a culture grown for 2 weeks in MM and then labeled in leucine-free Eagle's minimal essential medium containing 5.2 j&ml L-leucine plus normal DM components, 5% dialyzed FBS, and 50 &ml ascorbic acid. The positions of some identified bands are indicated (see Combrooks et al., 1983; . Samples were subjected to SDS-PAGE on linear 5-10% (lanes a-h) or 6% (lanes i-p) gels followed by fluorography. Each lane represents equal TCA-precipitable medium cpm; counts were determined prior to pepsin digestion for lanes i-p. Lanes a and b, whole media, and i and j, pepsindigested media, from 2 different cultures grown in DM. Lanes c and d, whole media, and k and Z, pepsin-digested media, from 2 different cultures grown in DM supplemented with ascorbic acid. Lanes e andf; whole media, and m and II, pepsin-digested media, from 2 different cultures grown in DM supplemented with dialyzed FBS. Lanes g and h, whole media, and o and p. pepsin-digested media, from 2 different cultures grown in DM supplemented with ascorbic acid and dialyzed FBS (MM). The positions of some identified bands are indicated (see Combrooks et al., 1983) . Lam, laminin A chain; pro ZV, type IV procollagen; IV, type IV collagen; Z, (Y-1 (upper) and a-2 (lower) chains of type I collagen; band beneath lower Z probably corresponds to a-2 (IV) -7OK. Arrowheads indicate the positions of molecular-weight standards, myosin (M, = 200,000), phosphorylase B (M, = 97,000), BSA (&& = 69,000), ovalbumin (M, = 46,000) carbonic anhydrase (M, = 30,000), and lactoglobulin A (M, = 18,000); in lanes i-p, the 2 lowest M, standards are not present. 'p i 0.05 (2-tailed) compared with DM by I test. dp < 0.005. with ascorbic acid alone (Fig. 2, c, d ) were similar to those secreted by cultures given ascorbic acid plus serum (MM; Fig.  2, g, h) . In addition, the pepsin-resistant collagens observed in the medium of cultures grown in DM supplemented with ascorbic acid alone were also similar to those in the medium of cultures grown in MM (cf. Fig. 2 , k and 1 with o and p).
Taken together, these results indicate that, whereas SCs grown on axons in DM are able to synthesize and secrete an array of proteins similar to that produced by fully differentiated SCs in MM, they are unable to produce significant amounts of the native, triple-helical collagens produced by SCs in MM. Furthermore, the ascorbic acid component of MM can account for the effects of MM on promoting the biosynthesis of triple-helical collagens, suggesting that triple-helical type IV (basement membrane) collagen production might mediate the effects of ascorbic acid on basal lamina assembly.
ODCs do not require ascorbic acid to form myelin The ODC forms myelin in CNS tissues without the concomitant deposition of a basal lamina (Peters et al., 1976) . This fact suggested that an examination of the influence of ascorbic acid on ODC myelination would reveal whether ascorbic acid plays a role in myelin formation per se, independent of its effects on basal lamina formation. Wood and Williams (1984) have shown that ODCs from embryonic spinal cord will interact with dorsal root ganglion cell axons in our culture system, initially proliferating and then forming myelin, and that such ODCs do not possess basal lamina. We therefore examined the requirements of ODC myelin formation for culture medium components previously shown to be required for SC myelin formation.
Suspensions of cells dissociated from embryonic day 15 spinal cord (containing ODC precursors) were plated onto cultures of purified dorsal root ganglion neurons. The cultures were maintained first in DM (2 weeks) and then in DM or various supplemented DMs (4 weeks) before being analyzed for myelin formation. As shown in Table 3 , in DM or DM supplemented with serum, ODCs formed 80-90% of the amount of myelin formed in DM supplemented with ascorbic acid and serum. In contrast, SCs exhibited an essentially absolute requirement for ascorbic acid (Table 3) . These results suggest that the dependence of SC myelination upon ascorbic acid is not due to a direct role of ascorbic acid in the biosynthesis or assembly of CNS glial cell-neuron cultures were grown in DM for 2 weeks and then in duplicate in the medium indicated for an additional 4 weeks. Abbreviations are given in Table 1 ; ascorbic acid was used at 50 pg/ml, and dFBS at 15%. For analysis, cultures were stained with antibody to P, to detect colonies of myelin-forming SCs, fixed, and stained with Sudan black, as described in Materials and Methods. ODC myelin formation was assessed by determination of the percentage of fields (0.024 mm*, 240 fields/culture) containing ODC myelin. An average of 8.5% of the fields in cultures grown in MM contained SC myelin and thus were counted as not containing ODC myelin; it was assumed that a similar proportion of fields in cultures grown in non-ascorbic acid-supplemented media contained non-myelinforming SCs. The experiment was performed twice; the percentage of fields containing ODC myelin in MM was 44% in one experiment and 70% in the other.
SC-neuron cultures were grown for 4 weeks in DM and then in duplicate in the medium indicated for an additional 2 weeks. SC myelin formation was quantitated after fixation and Sudan black staining by counting myelin segments . The experiment was performed twice; SC myelin segments/mm2 in MM were 3 I4 in one experiment and 279 in the other. 0 Average of values from duplicate cultures from duplicate experiments. Exogenous basal lamina substitutes for ascorbic acid-stimulated basal lamina production by SCs Our earlier work demonstrated that the promotion of SC basal lamina assembly by ascorbic acid is closely correlated with the stimulation of SC myelin formation. In order to determine if there is a causal link between SC basal lamina assembly and myelin formation, we provided exogenous basal lamina to SCs grown with neurons under media conditions in which the SCs are unable to assemble basal lamina of their own production, and we then determined the effect on myelin formation. SC-neuron cultures that had been maintained in DM were overlaid with either BLG, prepared from an extract of EHS sarcoma basal lamina matrix (Kleinman et al., 1986) or FCG, prepared from an extract of type I collagen-rich rat-tail tendon (Elsdale and Bard, 1972) , and were then maintained in DM or supplemented DMs for 2 weeks. Myelin formation was quantitated after staining the cultures with Sudan black. In SC-neuron cultures overlaid with BLG and maintained in DM, myelin was formed in quantities equal to those observed for control cultures given MM but no BLG (Table 4 , cf. Fig. 3, c, 6 ). Similar results were obtained when cultures overlaid with BLG were maintained in DM supplemented with serum (but without ascorbic acid, Table 4 ). The. ability of BLG to promote myelin formation by SCs in the absence of ascorbic acid was due specifically to the presence of basal lamina components and not simply to the presence of a gel overlay or extracellular matrix in general, as evidenced by the inability of FCG to promote myelin formation (Table 4) or even the required precedent morphological changes in the SCs (Fig. 3b) . The enhancement of myelin formation by BLG and FCG overlays in the presence of ascorbic acid (Table 4) is not understood, but it may be related to an earlier onset of myelination.
Electron microscopic examination of cultures grown in DM and fixed immediately after receiving BLG revealed that the Figure 4. Electron micrographs of cultures in DM within 20 min of (a, b) and 14 d after (c) the addition of BLG. a, Flattened SC processes facing the medium are covered by BLG matrix that has not permeated the subjacent fascicle of axons. b, An area just above the substratum; matrix is not seen in or around this fascicle of axons. The lack of ensheathment of axons is typical of growth in DM. c, Two weeks after BLG addition, matrix is seen beneath the culture surface; this material fills spaces between axonSC units and also may be observed to cover the SC surface in a lamina densa-like manner (arrowheads). In the 2-week period following the addition of BLG to a culture maintained in DM, myelin has formed and unmyelinated axons have become ensheathed with SC cytoplasm. a and b, x 24,000; c, x 38,500.
BLG matrix was initially distributed as a thick layer draped peared on most abaxonal SC surfaces, including those deep over the surfaces of the tissue (Fig. 4~) . Little matrix was seen within fascicles (Fig. 4~) . Accumulations of similar matrix maon SC surfaces not immediately adjacent to the BLG layer, and terial were also seen away from SC surfaces, filling extracellular none was observed within axon-SC fascicles (Fig. 4, a, b) . In spaces between neighboring SCs (Fig. 4~) . sibling cultures overlaid with BLG and then maintained in DM
The apparent redistribution of BLG matrix in this experiment for 2 weeks before fixation, a lamina densa-like layer had apsuggested that the gel property might be unimportant in the Table 4 . Exogenous basal lamina matrix promotes Schwann cell myelination in-the absence of ascorbic acid-, but fibrous collagen matrix does not SC-neuron cultures grown in DM for 4 weeks were maintained for an additional 2 weeks in the medium indicated and then processed for myelin quantitation SC-neuron cultures grown in DM for 4 weeks were given no overlay or FCG or BLG overlays (see Materials and Methods) and then maintained in DM or DM supplemented with 15% dialyzed FBS with or without 50 &ml ascorbic acid for 2 weeks. Cultures were fixed and stained with Sudan black, and the amount of myclin which had formed was quantitated . The values given are the averages from duplicate cultures from a representative experiment. Abbreviations are given in Table 1, effect of BLG on SC myelination. To test this idea we diluted BLG extract in DM so that it could not gel and determined the ability of such diluted extract to promote myelin formation in the absence of ascorbic acid. As shown in Table 5 , it promoted myelination comparable to that observed in MM, both in the presence and absence of serum and even at dilutions of 1:50-1 : 100; the addition of diluted matrix also led to the deposition on SC surfaces of laminin, type IV collagen, and HSPG, as determined by immunofluorescence (data not shown).
Laminin promotes SC myelin formation in the absence of ascorbic acid To determine whether any single component could substitute for the complex mixture present in the extract of basal lamina matrix, we tested 3 of the major known basal lamina molecules for their ability to promote SC myelination in the absence of ascorbic acid. Laminin at 50 &ml (50 nM, assuming lo6 gm/ mol; Timpl et al., 1979) , type IV collagen at 27 &ml (50 nM, assuming 5.4 x lo5 gm/mol; Kleinman et al., 1982) , and basal lamina HSPG at 3.75 &ml (5 nM, assuming 7.5 x lo5 gml mol; Ledbetter et al., 1985) were tested, both singly and in combination. As shown in Table 6 (Part l), 50 nM laminin, in SC neuron cultures grown in DM for 4 weeks were maintained for an additional 2 weeks in the medium indicated and then processed for myelin quantitation . The values given are averages (1) from duplicate cultures from a representative experiment or (2) from duplicate cultures from 3 experiments. Ascorbic acid was used at 50 fig/ml, and dFBS was used at 15%. IV indicates type IV collagen; other abbreviations are given in Table 1 . Ice-cold basal lamina components were diluted into ice-cold DM or DM supplemented with dFBS. Basal lamina component molar ratios were chosen to reflect the ratios likely to exist in viva (Kleinman et al., 1983) . the absence of ascorbic acid, promoted myelin formation that was nearly as extensive as that observed in control cultures given MM, but neither type IV collagen nor HSPG had any significant effect on myelination. Neither higher concentrations (33 nM) of HSPG nor a combination of type IV collagen and HSPG (50:5 nM) promoted myelination (data not shown); in addition, these 2 molecules did not appear to enhance the effect of laminin significantly, either at high (50 nM) or at suboptimal (10 nM) laminin concentrations (Table 6 , Part 1). The effect of laminin addition was observed with laminin obtained from 3 sources (including one noncommercial) and was very consistent from one experiment to another (Table 6 , Part 2). The effect of laminin was influenced by serum (Table 6 ), in contrast to the effect obtained with BLG matrix (Tables 4 and 5 ).
Examination of cultures by electron microscopy showed that lamina densa-like layers had accumulated on abaxonal SC surfaces in the presence of exogenous laminin (Fig. 5a ) and also that similar-appearing material frequently filled extracellular spaces between SCs (Fig. 5a ), in contrast to basal lamina formed in response to ascorbic acid (Fig. 5b) . Surprisingly, when deposition of basal lamina was assessed by immunofluorescence using antibodies to individual basal lamina components, it was found that the addition of exogenous laminin to the culture medium resulted in the deposition on the SC surface of not only laminin but also type IV collagen and HSPG (Fig. 6, f-h) ; the intensity of antibody staining observed in this case was at least as great as that seen in control cultures in which endogenous basal lamina assembly had been promoted by ascorbic acid (cf. Fig. 6, f-h and j-l ) . Experiments (not shown) were performed to confirm the apparent deposition of type IV collagen in response to exogenous laminin. First, laminin purified by the method of Timpl et al. (1979) and free of detectable type IV collagen (as determined by both Western blotting and ELBA with polyclonal antibodies to type IV collagen; E. Crouch, personal communication) promoted myelination and the deposition of type IV collagen (as determined by immunofluorescence) comparable with that obtained with commercial laminin preparations. Second, 3 additional antibodies to type IV collagen (one additional antibody to the NC1 domain of EHS sarcoma, one to reduced and alkylated EHS sarcoma, and one to human placental type IV collagen) were all found to stain laminin-induced matrix as described above for the NC1 antibody. These results provide strong evidence that the type IV collagen being deposited was derived from SCs and not from contaminants of the laminin preparations.
Attempts to directly demonstrate SC type IV collagen in laminin-induced matrix were only partially successful. Cultures grown in the presence of either ascorbic acid or laminin (with and without serum) were labeled for 24 hr with 35S-methionine, the cell layers were extracted with 4 M guanidine, and the extracts were dialyzed into immunoprecipitation buffer. All 4 type IV collagen antibodies described above could specifically immunoprecipitate type IV procollagen from extracts of laminintreated cultures (Fig. 7a, lanes 3 and 4) but only in small amounts relative to ascorbic acid-treated cultures (Fig. 7a, lane 2) . The type IV procollagen precipitated from extracts of laminin-treat- a, Cell layer samples were extracted with 4 M guanidine, dialyzed into immunoprecipitation buffer, and subjected to immunoprecipitation using rabbit anti-type IV collagen NC1 domain (lanes 1-4) or normal rabbit serum (lane 5), and the precipitates were analyzed by SDS-PAGE on 6% gels. The asterisk designates the type IV procollagen doublet in lane 2. Medium (b) and cell layer (c) samples were digested with pepsin and analyzed by SDS-PAGE on 6% gels. Each pair of lanes (I-2, 3-4 etc.) represents material from duplicate cultures grown in the same medium. IV, type IV collagen; Z, type I collagen. ed cultures migrated slightly faster than that of ascorbic acidtreated cultures (Fig. 7a, lanes 2 and 3) , but the precipitated material was sensitive to bacterial collagenase in both cases (data not shown). Our failure to detect large amounts of SC type IV collagen in these cultures might have been due to an unusual sensitivity of antigenic determinants in non-triple-helical type IV collagen to our extraction procedures. In contrast to ascorbic acid supplementation (Fig. 7, b, c, lanes 3 and 4) , no pepsinresistant collagen was detectable in media (Fig. 7b, or cell layers (Fig. 7c , lanes 5-8) of laminin-treated cultures, indicating that the type IV collagen deposited with laminin addition was not triple-helical.
Discussion
Abundant evidence now exists demonstrating that extracellular matrices are important to cells and tissues, not only for their structural attributes but also for their permissive and even instructive properties with respect to cell proliferation, migration, and differentiation (Kleinman et al., 1981; Sanes, 1983; Hay, 1984; Ekblom et al., 1986 ). Our results demonstrate a profound requirement of basal lamina matrix for the best-known function of differentiated SCs, myelin formation. Initial work from our laboratory demonstrated that, although SCs can proliferate in the absence of basal lamina (in DM) in response to a mitogen on the surface of axons of dorsal root ganglion neurons, they are unable to differentiate into myelin-forming cells (Moya et al., 1980) . Subsequent investigations revealed that SCs require ascorbic acid and a nondialyzable serum factor(s), in addition to axons , in order to assemble basal lamina and form myelin; similar dose-response characteristics are observed for the stimulation by ascorbic acid of these 2 aspects of SC differentiation . Data presented in this paper demonstrate that SCs do not require either ascorbic acid or serum to myelinate axons if they are given basal lamina components from exogenous sources. These data thus support the hypothesis that ascorbic acid acts to enable SCs to form basal lamina and that basal lamina in turn enables SCs to myelinate axons.
In an attempt to determine how ascorbic acid acts to promote SC basal lamina assembly, the synthesis and secretion of protein by SCs grown with neurons in different media were examined.
The results demonstrated that, although there were often significant quantitative differences in total protein synthesis and/ or secretion between cultures maintained in different media (and therefore at different stages of differentiation) within an experiment, there was no overall correlation of differences in these general measures of protein biosynthetic processes with stages of SC differentiation. Evaluation of secreted protein by SDS-PAGE showed that, with a few exceptions, SCs in DM secreted an array of proteins strikingly similar to that in MM.
Our results contrast significantly with those of Carey and Bunge (198 I) , who reported that a single protein accounts for essentially all protein secreted by SCs grown with neurons in DM. Because we obtained consistent results using 3 different labeling protocols (including those of Carey and Bunge), we are confident that our results reflect SC protein secretion occurring in DM. Carey and Todd (1987) Carey and Todd (1987) ; the most significant outcome of these modifications is that we no longer observe the regional degeneration of axons awaiting the slow repopulation of SCs that occurs in cultures prepared by the older method C. F. Eldridge and R. P, Bunge, unpublished observations) . It is possible that proteases released from degenerating axons (Schlaepfer, 1983) could significantly degrade proteins secreted by SCs in DM and yield the results reported by Carey and Bunge (198 1) and Carey and Todd (1987) . Although we observed that SCs in DM exhibited a secretory repertoire similar to that in MM, only SCs in MM were found to synthesize pepsin-resistant, triple-helical collagen; the ascorbic acid component accounted for this effect of MM. A mechanism to account for the effect of ascorbic acid on SC collagen biosynthesis is well established in the literature: Ascorbic acid acts as a cofactor for prolyl hydroxylase which forms, from collagen-bound proline, the hydroxyproline residues essential for the formation and stabilization of the collagen triple-helix (reviewed by Prockop et al., 1976; Kivirikko and Myllyla, 1982) . There is evidence suggesting that, at least for interstitial (fibrous) collagens, the lack of a triple-helical conformation increases the susceptibility of collagen chains to degradation intracellularly soon after synthesis (Berg et al., 1980; Neblock and Berg, 1982) and also reduces the rate of secretion of collagen chains, the net result being a severely reduced rate of appearance of functional collagen at the cell surface. Less is known about the role of the triple-helix in type IV collagen secretion and function. Karakashian and Kefalides (1982) reported that the rate of secretion of non-triple-helical type IV collagen in 50% of that of its fully hydroxylated counterpart, a difference comparable to that observed for type I collagen but that no intracellular degradation is detectable. Kleinman et al. (1983) have shown that denaturation (boiling) of type IV collagen leads to the loss of ability to interact with other basal lamina constituents. It is not clear, however, that denatured type IV collagen is equivalent to nontriple-helical (underhydroxylated) type IV collagen, especially considering that important interactions occur at the globular, noncollagenous C-terminal domain of the type IV collagen molecule (Tsilibary and Charonis, 1986) . Our immunofluorescence results (from cultures given exogenous laminin) would suggest that non-triple-helical type IV collagen can interact with other basal lamina components and thus deposit in the matrix. The role of triple-helical collagen in basal lamina assembly is discussed below.
In the experiments reported here we tested the hypothesis that the availability of ascorbic acid leads to SC basal lamina formation, which then leads to myelination. First, we demonstrated that ascorbic acid is unlikely to be directly involved in the biosynthesis and assembly of SC myelin, since myelin formation by ODCs, the non-basal lamina-forming myelinating cell of the CNS, was little affected by ascorbic acid. Second, we provided SCs with an extract of basal lamina matrix in the absence of ascorbic acid and determined whether they could then form myelin. The results of those experiments strongly support our hypothesis, since BLGs promoted control levels of myelination in the absence of ascorbic acid and enabled SCs to acquire basal lamina components on their surfaces. Gels of interstitial collagen (FCGs) did not promote myelination in the absence of ascorbic acid, indicating that the effect of BLGs was specifically due to basal lamina components. Electron microscopic comparison of cultures immediately and 2 weeks after BLG addition suggested that SCs could utilize soluble components originating from the BLG. Subsequent experiments using BLG matrix diluted so that it could not gel verified that the critical property of the matrix was its content of basal lamina components, not its ability to form a gel. These experiments confirm the original observation made by Carey et al. (1986) that BLGs promote myelin formation by SCs grown with ncurons in DM, and they extend it by (1) presenting quantitative data on myelin formation, (2) demonstrating that the cffcct is specific for BLG, (3) directly demonstrating that non-gcl-forming basal lamina extract is fully active in promoting myelination, and (4) illustrating in electron micrographs that the SC surface acquires lamina densa-like structures.
We tested 3 of the major known basal lamina molecules for activity in promoting myelin formation in the absence of ascorbic acid and found that only laminin had any activity, promoting near-control levels of myelination. The ability of laminin to promote myelination was enhanced by serum, in contrast to BLG (from which laminin was purified), suggesting that serum either supplies the SC with or induces the SC to synthesize a minor or unknown molecule(s) required for the forming basal lamina structure to acquire full biological activity. Alternatively, considering the relatively impure nature of the BLG (a crude extract), its full myelin-promoting activity in the absence of serum might be due to non-basal lamina contaminants.
We were surprised to find not only that exogenous type IV collagen did not promote myelination, but that provision of exogenous laminin led to bright fluorescence staining for type IV collagen in the absence of ascorbic acid. Since purified laminin known to have no detectable type IV collagen contamination promoted type IV collagen deposition (as well as myelination), the type IV collagen had to originate from SCs. We were unable, however, to directly demonstrate biochemically (by metabolic labeling and immunoprecipitation) the large amounts of SC type IV collagen we expected to see deposited in the matrix in response to exogenous laminin. As mentioned in Results, this result may indicate an exceptional sensitivity of non-triple-helical type IV collagen antigenic determinants to the extraction procedures used.
The apparent equivalence of laminin and ascorbic acid, and nonequivalence of type IV collagen, in promoting basal lamina formation and myelination is puzzling. Exogenous laminin bound abundantly and rapidly (< 1 hr) to the surface of SCs grown with neurons in DM, indicating a large number of unoccupied laminin binding sites (a result also obtained with purified SCs by McGarvey et al., 1984) , whereas barely detectable amounts of exogenous type IV collagen bound during 2 weeks of exposure, as determined by immunofluorescence (data not shown). It may be that, by binding to laminin receptors (Brown et al., 1983; Terranova et al., 1983) on the SC surface, exogenous laminin reaches locally high concentrations sufficient to initiate selfassembly and/or complex formation with other SC-derived basal lamina components; the laminin concentrations used in our experiments were below that required for self-assembly (Yurchenco et al., 1985) . It is not known whether the co-deposition of non-triple-helical type IV collagen and HSPG along with laminin was coincidental or was essential for that deposition and the myelination that it enabled. Exogenous type IV collagen may have failed to promote basal lamina formation simply because it did not significantly bind to the SC surface. In addition, type IV collagen secreted by cells and incorporated into developing basal lamina may initially be in a monomeric form, whereas the EHS type IV collagen used in these experiments
The Journal of Neuroscience, February 1989, 9(2) 637 consists predominantly of dimers (Yurchenco and Furthmayr, 1984) ; it is possible, therefore, that the exogenous type IV collagen was in the wrong form for SCs to utilize for basal lamina assembly. Endogenous, triple-helical type IV collagen, synthesized by the SC in the presence of ascorbic acid, could initiate basal lamina formation by (1) interacting with laminin and other basal lamina molecules prior to or during secretion, thereby forming complexes (Kleinman et al., 1983 (Kleinman et al., , 1986 ) that could deposit on the SC surface by binding to receptors and/or previously assembled complexes or (2) enabling the efficient transport and secretion of other basal lamina molecules. The results of Vogel and coworkers (reviewed in Vogel et al., 1987) on the effects of an ascorbic acid-like molecule from embryonic brain on skeletal muscle cell basal lamina formation and differentiation (ACh receptor aggregation) show remarkable parallels to our results with SC basal lamina formation and differentiation. Both sets of observations raise the possibility that neurons may control basal lamina production (and thus further differentiation such as myelination) by acting as "purveyors" of ascorbic acid to the cells they contact. Although the neuron could be a source of ascorbic acid for the developing SC in vivo-in the rat, ascorbic acid is synthesized only in the liver (Chatterjee, 1973) -evidence suggests that the neuron does not control whether and when the SC myelinates by simply inducing basal lamina formation. Both myelinating and nonmyelinating (ensheathing) SCs acquire basal laminae (Peters et al., 1976) . In addition, SCs in developing peripheral nerve acquire basal lamina at a very early stage, at which time axons abut one another with no intervening SC processes (Cravioto, 1965; Gamble, 1966; Ochoa, 197 l) , so that SC proliferation, axon sorting, and ensheathment and myelination occur with the SCs always in association with basal lamina (see Martin and Webster, 1973; Webster et al., 1973) . Our in vitro experiments, however, have allowed us to study SCs without basal lamina and thus to demonstrate the SC's dependence on this structure for myelination. It may be that basal lamina is required to enable the SC to generate the plasma membrane polarity and cytoskeletal organization needed to execute the complex shape changes that differentiation, including myelin formation, requires Bunge et al., 1986; . As we have discussed elsewhere , the mutant dystrophic mouse may represent an in vivo corollary of this observation; axons are not myelinated in areas where SCs exhibit basal lamina deficiency. The ability to culture various combinations of normal and dystrophic SCs and neurons and to initiate basal lamina formation by several different means (ascorbic acid, basal lamina matrix, and purified laminin) makes this SC-neuron culture system attractive as a model for the study of mechanisms by which the cell controls, accomplishes, and responds to basal lamina assembly.
